about
Neutrophils: positive or negative?Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemiaAntibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentAuthor Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentNull donors favor prepared immunologistsComplement alone drives efficacy of a chimeric antigonococcal monoclonal antibody
P50
Q30252480-7AFBB1BA-EF1C-4597-9864-DC192E339872Q30276082-07942093-C714-4F2E-935F-5AF92AB88626Q30276243-1662B5AC-653A-4598-8AF6-614D8B2C6211Q38730371-4C19E66A-CF97-4F9B-90FF-B0188874BEF6Q90340810-FF864B01-C919-444F-ABF7-6D295A4F65F8Q90664000-1D4D9B2D-C5FF-4DDF-B0E6-A1B20AABD334Q92686652-43A79D59-0B09-4023-B7C1-F3A95E6FDE1EQ92876720-5B1A3694-151B-44B3-B5A2-09E4B03D6506
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ronald P Taylor
@ast
Ronald P Taylor
@en
Ronald P Taylor
@es
Ronald P Taylor
@nl
type
label
Ronald P Taylor
@ast
Ronald P Taylor
@en
Ronald P Taylor
@es
Ronald P Taylor
@nl
prefLabel
Ronald P Taylor
@ast
Ronald P Taylor
@en
Ronald P Taylor
@es
Ronald P Taylor
@nl
P106
P31
P496
0000-0003-1578-8382